Insider Transactions in Q2 2021 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2021
|
Michael R Hayden Director |
SELL
Open market or private sale
|
Indirect |
100,000
-9.06%
|
$2,500,000
$25.5 P/Share
|
|
Jun 18
2021
|
Dcvc Bio, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
73,892
+50.0%
|
-
|
|
Jun 18
2021
|
Dcvc Bio, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
5,000,000
-17.18%
|
-
|
|
Jun 18
2021
|
John Hamer Director |
BUY
Other acquisition or disposition
|
Indirect |
73,892
+50.0%
|
-
|
|
Jun 18
2021
|
John Hamer Director |
SELL
Other acquisition or disposition
|
Indirect |
5,000,000
-17.18%
|
-
|
|
Jun 15
2021
|
Veronique Lecault Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
333,333
+19.93%
|
$0
$0.19 P/Share
|
|
Jun 09
2021
|
Andrew Booth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,200,000
-100.0%
|
$30,000,000
$25.5 P/Share
|
|
Jun 09
2021
|
Ester Falconer Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,000,000
-100.0%
|
$25,000,000
$25.5 P/Share
|
|
Jun 09
2021
|
Tryn Stimart Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,000,000
-99.98%
|
$25,000,000
$25.5 P/Share
|
|
Jun 09
2021
|
Veronique Lecault Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
1,000,000
-78.52%
|
$25,000,000
$25.5 P/Share
|
|
Jun 09
2021
|
Carl L. G. Hansen Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
6,000,000
-36.19%
|
$144,000,000
$24.77 P/Share
|
|
Jun 09
2021
|
Thermopylae Holdings Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,598,420
-9.15%
|
$134,362,080
$24.03 P/Share
|
|
Jun 07
2021
|
Andrew Booth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200,000
+41.67%
|
$0
$0.26 P/Share
|
|
Jun 07
2021
|
Tryn Stimart Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000,000
+34.99%
|
$1,000,000
$1.31 P/Share
|